When is the Optimal Time for Surgery after Neoadjuvant Chemoimmunotherapy in NSCLC? A Multi-Center Analysis

Tae Hee Hong1, Yeong Jeong Jeon2, Young Ho Yang1, Ha Eun Kim1, Byung Jo Park1, Jin Gu Lee1, Dae Joon Kim1, Junghee Lee2, Seong Yong Park2, Jong Ho Cho2, Yong Soo Choi2, Hong Kwan Kim2, Chang Young Lee1 1Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea; 2Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

첨부파일 : KTCVS_Abstract_timing.pdf

책임저자: Chang Young Lee

연세대학교 세브란스병원

발표자: Tae Hee Hong, E-mail : thhongcs@yuhs.ac